Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>

<i>Leishmania infantum</i> is the etiological agent of visceral leishmaniasis (VL) in South America, the Mediterranean basin, and West and Central Asia. The most affected country, Brazil, reported 4297 VL cases in 2017. <i>L. infantum</i> is transmitted by female phlebotomine...

Full description

Bibliographic Details
Main Authors: Mayara Castro de Morais, Gisele Alves Medeiros, Fernanda Silva Almeida, Juliana da Câmara Rocha, Yunierkis Perez-Castillo, Tatjana de Souza Lima Keesen, Damião Pergentino de Sousa
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/6/2844
_version_ 1797609886449664000
author Mayara Castro de Morais
Gisele Alves Medeiros
Fernanda Silva Almeida
Juliana da Câmara Rocha
Yunierkis Perez-Castillo
Tatjana de Souza Lima Keesen
Damião Pergentino de Sousa
author_facet Mayara Castro de Morais
Gisele Alves Medeiros
Fernanda Silva Almeida
Juliana da Câmara Rocha
Yunierkis Perez-Castillo
Tatjana de Souza Lima Keesen
Damião Pergentino de Sousa
author_sort Mayara Castro de Morais
collection DOAJ
description <i>Leishmania infantum</i> is the etiological agent of visceral leishmaniasis (VL) in South America, the Mediterranean basin, and West and Central Asia. The most affected country, Brazil, reported 4297 VL cases in 2017. <i>L. infantum</i> is transmitted by female phlebotomine sand flies during successive blood meals. There are no validated vaccines to prevent the infection and the treatment relies on drugs that often present severe side effects, which justify the efforts to find new antileishmanial drugs. Cinnamic acid derivatives have shown several pharmacological activities, including antiparasitic action. Therefore, in the present study, the biological evaluation of cinnamic acid and thirty-four derivatives against <i>L. infantum</i> is reported. The compounds were prepared by several synthesis methods and characterized by spectroscopic techniques and high-resolution mass spectrometry. The results revealed that compound <b>32</b> (N-(4-isopropylbenzyl)cinnamamide) was the most potent antileishmanial agent (IC<sub>50</sub> = 33.71 μM) with the highest selectivity index (SI > 42.46), followed by compound <b>15</b> (piperonyl cinnamate) with an IC<sub>50</sub> = 42.80 μM and SI > 32.86. Compound <b>32</b> was slightly less potent and nineteen times more selective for the parasite than amphotericin B (MIC = 3.14 uM; SI = 2.24). In the molecular docking study, the most likely target for the compound in <i>L. infantum</i> was aspartyl aminopeptidase, followed by aldehyde dehydrogenase, mitochondrial. The data obtained show the antileishmanial potential of this class of compounds and may be used in the search for new drug candidates against <i>Leishmania</i> species.
first_indexed 2024-03-11T06:06:49Z
format Article
id doaj.art-dce3613366804372aa47e382ee58c441
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T06:06:49Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-dce3613366804372aa47e382ee58c4412023-11-17T12:55:57ZengMDPI AGMolecules1420-30492023-03-01286284410.3390/molecules28062844Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>Mayara Castro de Morais0Gisele Alves Medeiros1Fernanda Silva Almeida2Juliana da Câmara Rocha3Yunierkis Perez-Castillo4Tatjana de Souza Lima Keesen5Damião Pergentino de Sousa6Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, BP, BrazilDepartment of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, BP, BrazilImmunology of Infectious Diseases Laboratory, Department of Cellular and Molecular Biology, Federal University of Paraiba, João Pessoa 58051-900, BP, BrazilImmunology of Infectious Diseases Laboratory, Department of Cellular and Molecular Biology, Federal University of Paraiba, João Pessoa 58051-900, BP, BrazilBio-Cheminformatics Research Group and Area de Ciencias Aplicadas, Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Americas, Quito 170503, EcuadorImmunology of Infectious Diseases Laboratory, Department of Cellular and Molecular Biology, Federal University of Paraiba, João Pessoa 58051-900, BP, BrazilDepartment of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, BP, Brazil<i>Leishmania infantum</i> is the etiological agent of visceral leishmaniasis (VL) in South America, the Mediterranean basin, and West and Central Asia. The most affected country, Brazil, reported 4297 VL cases in 2017. <i>L. infantum</i> is transmitted by female phlebotomine sand flies during successive blood meals. There are no validated vaccines to prevent the infection and the treatment relies on drugs that often present severe side effects, which justify the efforts to find new antileishmanial drugs. Cinnamic acid derivatives have shown several pharmacological activities, including antiparasitic action. Therefore, in the present study, the biological evaluation of cinnamic acid and thirty-four derivatives against <i>L. infantum</i> is reported. The compounds were prepared by several synthesis methods and characterized by spectroscopic techniques and high-resolution mass spectrometry. The results revealed that compound <b>32</b> (N-(4-isopropylbenzyl)cinnamamide) was the most potent antileishmanial agent (IC<sub>50</sub> = 33.71 μM) with the highest selectivity index (SI > 42.46), followed by compound <b>15</b> (piperonyl cinnamate) with an IC<sub>50</sub> = 42.80 μM and SI > 32.86. Compound <b>32</b> was slightly less potent and nineteen times more selective for the parasite than amphotericin B (MIC = 3.14 uM; SI = 2.24). In the molecular docking study, the most likely target for the compound in <i>L. infantum</i> was aspartyl aminopeptidase, followed by aldehyde dehydrogenase, mitochondrial. The data obtained show the antileishmanial potential of this class of compounds and may be used in the search for new drug candidates against <i>Leishmania</i> species.https://www.mdpi.com/1420-3049/28/6/2844cinnamatecinnamamidenatural productmedicinal plantantiparasitic activity
spellingShingle Mayara Castro de Morais
Gisele Alves Medeiros
Fernanda Silva Almeida
Juliana da Câmara Rocha
Yunierkis Perez-Castillo
Tatjana de Souza Lima Keesen
Damião Pergentino de Sousa
Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
Molecules
cinnamate
cinnamamide
natural product
medicinal plant
antiparasitic activity
title Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
title_full Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
title_fullStr Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
title_full_unstemmed Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
title_short Antileishmanial Activity of Cinnamic Acid Derivatives against <i>Leishmania infantum</i>
title_sort antileishmanial activity of cinnamic acid derivatives against i leishmania infantum i
topic cinnamate
cinnamamide
natural product
medicinal plant
antiparasitic activity
url https://www.mdpi.com/1420-3049/28/6/2844
work_keys_str_mv AT mayaracastrodemorais antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT giselealvesmedeiros antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT fernandasilvaalmeida antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT julianadacamararocha antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT yunierkisperezcastillo antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT tatjanadesouzalimakeesen antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi
AT damiaopergentinodesousa antileishmanialactivityofcinnamicacidderivativesagainstileishmaniainfantumi